$56,704,950

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechexpiredONGOING · MOD OF 2018 CONTRACT

WORK BEGAN2018-09-25·LATEST ACTION2026-05-08·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50118C00024_7505_-NONE-_-NONE-

Award description

IGF::OT::IGF

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: medium

In plain English

Latest obligation on ASPR's 2018 medical countermeasures contract with MAPP Biopharmaceutical.

Sub-sectors

medical-countermeasurespandemic-preparednesspharma-contract

Why this matters

Long-term U.S. investment in medical countermeasures and biodefense capabilities for pandemic response.

Supply-chain signal

Sustained domestic manufacturing investment in antiviral and medical countermeasure production capacity.

U.S.–China competition angle

Advances U.S. biodefense autonomy amid rising competition in vaccine and therapeutic development.

Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-06-08. Cost: $0.017034.

Period of performance

Start

2018-09-25

End

2024-12-31

Status

expired547 days ago

Recipient

Other awards from this recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50118C00024_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.